Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Geratherm Medical (0EL9) AI Stock Analysis

Top Page

GB:0EL9

Geratherm Medical

(LSE:0EL9)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Conservative Balance SheetLow leverage and a substantial equity base provide financial flexibility for a small medical-device business. This structure can help Geratherm withstand weaker operating periods, support continued product commercialization, and reduce dependence on external financing.
Negative Factors
Severe Revenue WeaknessThe sharp revenue contraction indicates weakened demand, distribution, or product momentum and reduces the scale over which fixed operating costs can be absorbed. Persistent top-line weakness would limit investment capacity and make a durable earnings recovery more difficult.

Geratherm Medical (0EL9) vs. iShares MSCI United Kingdom ETF (EWC)

-50%-40%-30%-20%-10%0%10%20%30%GB:0EL9-40.16%EWC+21.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 11.71M
Dividend Yield
4.70%
Average Volume (3M)
52
Price to Earnings (P/E)
-15.4
Beta (1Y)
0.40
Revenue Growth
1.58%
EPS Growth
-148.73%
Country
UK
Employees
136
Sector
General
Sector Strength
55
Industry
Medical - Devices

Geratherm Medical Business Overview & Revenue Model

Company Description

Geratherm Medical AG, a German-based medical technology enterprise, organizes its operations across four primary divisions: Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems. The Healthcare Diagnostic unit offers a range...

Geratherm Medical Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

GB:0EL9 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
DE:SHLDE:SHL70OutperformEUR 47.86B21.6612.00%2.33%-0.92%2.06%
DE:M3VDE:M3V66NeutralEUR 37.13M26.847.77%4.66%-6.92%-67.82%
DE:DRW3DE:DRW365NeutralEUR 1.64B11.1610.20%2.23%5.06%40.18%
DE:SBSDE:SBS57NeutralEUR 273.51M-562.50-0.17%2.67%――
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-50%0%50%GB:0EL9DE:DRW3DE:M3VDE:SBSDE:SHLDE:E8XDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
GB:0EL9 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:0EL9Geratherm Medical2.25-1.90-45.73%
DE:DRW3Draegerwerk AG & Co. KGaA102.0031.8245.34%
DE:M3VMeVis Medical Solutions20.40-3.31-13.95%
DE:SBSSTRATEC Biomedical22.500.321.43%
DE:SHLSiemens Healthineers42.89-4.78-10.03%
DE:E8Xelexxion AG0.01-0.13-90.71%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.